ABVC looks like a tiny biotech, a licensing company, a CDMO, and a Taiwan real-asset story in the same filing. The first proof gate is whether cash, controls, and partners can catch up to the size of the pipeline.
References
Sources used in this report
SEC issuer filing indexSEC submissions index for ABVC BioPharma, Inc.2026-05-13 · CIK, ticker, exchange, filing inventory, and latest source discovery.SEC company factsSEC XBRL company facts for ABVC BioPharma, Inc.2026-05-13 · Financial cross-checks for revenue, expenses, cash, assets, liabilities, equity, shares, and cash flow.Annual reportABVC FY2025 Form 10-K2026-03-03 · Business model, pipeline, financials, going concern, controls, restatement, employees, governance, related parties, and risk factors.Amended quarterly reportABVC Q3 2025 Form 10-Q/A2026-03-03 · Restated Q3 financials, revenue reversal, cash, working capital, financing, and going-concern update.Company results releaseABVC FY2025 results release2026-03-03 · Management framing for the asset-backed licensing model and pipeline summary.Current reportABVC Form 8-K non-reliance disclosure2026-03-03 · Disclosure that the September 2025 quarterly financial statements should no longer be relied upon and revenue was reversed.Proxy statementABVC 2026 definitive proxy statement2026-03-05 · Board, management, ownership, incentive plan proposal, and related-party governance context.Current reportABVC 2026 annual meeting Form 8-K2026-03-27 · Voting results for directors, auditor ratification, and equity-plan increase.Registration statementABVC post-effective amendment prospectus2026-03-27 · Warrant-share registration, potential warrant cash proceeds, outstanding shares, and dilution context.Official company product pageABVC product pipeline page2026-05-13 · Official product menu and pipeline categories.Government registryClinicalTrials.gov PDC-1421 registry search2026-05-13 · Registry check for PDC-1421 depression and ADHD studies.Government registryClinicalTrials.gov ABV-1701 registry search2026-05-13 · Registry check for ABV-1701/Vitargus studies.Regulator guidanceFDA Botanical Drug Development guidance2016-12 · Regulatory context for botanical drug development evidence, quality, and approval requirements.